Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 904

1.

Response-adapted intensification with cyclophosphamide, bortezomib, and dexamethasone versus no intensification in patients with newly diagnosed multiple myeloma (Myeloma XI): a multicentre, open-label, randomised, phase 3 trial.

Jackson GH, Davies FE, Pawlyn C, Cairns DA, Striha A, Collett C, Waterhouse A, Jones JR, Kishore B, Garg M, Williams CD, Karunanithi K, Lindsay J, Wilson JN, Jenner MW, Cook G, Kaiser MF, Drayson MT, Owen RG, Russell NH, Gregory WM, Morgan GJ; UK NCRI Haematological Oncology Clinical Studies Group.

Lancet Haematol. 2019 Oct 14. pii: S2352-3026(19)30167-X. doi: 10.1016/S2352-3026(19)30167-X. [Epub ahead of print]

2.

Analysis of the clinical impact of NPM1 mutant allele burden in a large cohort of younger adult patients with acute myeloid leukaemia.

Linch DC, Hills RK, Burnett AK, Russell N, Gale RE.

Br J Haematol. 2019 Oct 8. doi: 10.1111/bjh.16239. [Epub ahead of print]

PMID:
31595497
3.

Analysis of data collected in the European Society for Blood and Marrow Transplantation (EBMT) Registry on a cohort of lymphoma patients receiving plerixafor.

Sureda A, Chabannon C, Masszi T, Pohlreich D, Scheid C, Thieblemont C, Wahlin BE, Sakellari I, Russell N, Janikova A, Dabrowska-Iwanicka A, Touzeau C, Esquirol A, Jantunen E, van der Werf S, Bosman P, Boumendil A, Liu Q, Celanovic M, Montoto S, Dreger P.

Bone Marrow Transplant. 2019 Sep 30. doi: 10.1038/s41409-019-0693-z. [Epub ahead of print]

PMID:
31570781
4.

Simultaneous Tracking of Pseudomonas aeruginosa Motility in Liquid and at the Solid-Liquid Interface Reveals Differential Roles for the Flagellar Stators.

Hook AL, Flewellen JL, Dubern JF, Carabelli AM, Zaid IM, Berry RM, Wildman RD, Russell N, Williams P, Alexander MR.

mSystems. 2019 Sep 24;4(5). pii: e00390-19. doi: 10.1128/mSystems.00390-19.

5.

Time-dependent hemeoxygenase-1, lipocalin-2 and ferritin induction after non-contusion traumatic brain injury.

Russell NH, Black RT, Lee NN, Doperalski AE, Reeves TM, Phillips LL.

Brain Res. 2019 Sep 17;1725:146466. doi: 10.1016/j.brainres.2019.146466. [Epub ahead of print]

6.

Results from a multicenter, noninterventional registry study for multiple myeloma patients who received stem cell mobilization regimens with and without plerixafor.

Morris C, Chabannon C, Masszi T, Russell N, Nahi H, Kobbe G, Krejci M, Auner HW, Pohlreich D, Hayden P, Basak GW, Lenhoff S, Schaap N, van Biezen A, Knol C, Iacobelli S, Liu Q, Celanovic M, Garderet L, Kröger N.

Bone Marrow Transplant. 2019 Sep 18. doi: 10.1038/s41409-019-0676-0. [Epub ahead of print]

PMID:
31534192
7.

Cohesin-dependent regulation of gene expression during differentiation is lost in Cohesin-mutated myeloid malignancies.

Sasca D, Yun H, Giotopoulos G, Szybinski J, Evan T, Wilson NK, Gerstung M, Gallipoli P, Green AR, Hills RK, Russell NH, Osborne CS, Papaemmanuil E, Gottgens B, Campbell PJ, Huntly BJP.

Blood. 2019 Sep 12. pii: blood.2019001553. doi: 10.1182/blood.2019001553. [Epub ahead of print]

PMID:
31515253
8.

Health care use and remaining needs for support among women with breast cancer in the first 15 months after diagnosis: the role of the GP.

Lo-Fo-Wong DN, de Haes HC, Aaronson NK, van Abbema DL, Admiraal JM, den Boer MD, Hezewijk MV, Immink M, Kaptein AA, Menke-Pluijmers MB, Russell NS, Schriek M, Sijtsema S, van Tienhoven G, Sprangers MA.

Fam Pract. 2019 Aug 27. pii: cmz043. doi: 10.1093/fampra/cmz043. [Epub ahead of print]

PMID:
31504455
9.

End-of-life care in hospital.

Russell N.

Intern Med J. 2019 Aug;49(8):1056. doi: 10.1111/imj.14385. No abstract available.

PMID:
31387145
10.

Prognostic impact of EBV serostatus in patients with lymphomas or chronic malignancies undergoing allogeneic HCT.

Styczynski J, Tridello G, Gil L, Ljungman P, Mikulska M, Ward KN, Cordonnier C, de la Camara R, Averbuch D, Knelange N, Socié G, Chevallier P, Blaise D, Yakoub-Agha I, Forcade E, Cornelissen J, Maertens J, Petersen E, Nguyen-Quoc S, Veelken H, Schaap N, Passweg J, Michallet M, Fegueux N, Deconinck E, Russell N, Basak G, Bader P, Montoto S, Kröger N, Cesaro S; Infectious Diseases Working Party EBMT.

Bone Marrow Transplant. 2019 Jul 30. doi: 10.1038/s41409-019-0627-9. [Epub ahead of print]

PMID:
31363166
11.

Preventing conversion to open surgery during laparoscopic donor nephrectomy complicated by bleeding from the aorta.

Georgiades F, Kosmoliaptsis V, Nicholson ML, Russell NK.

Clin Transplant. 2019 Jul 22:e13653. doi: 10.1111/ctr.13653. [Epub ahead of print] No abstract available.

PMID:
31328827
12.

Publisher Correction: Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial.

Voorwerk L, Slagter M, Horlings HM, Sikorska K, van de Vijver KK, de Maaker M, Nederlof I, Kluin RJC, Warren S, Ong S, Wiersma TG, Russell NS, Lalezari F, Schouten PC, Bakker NAM, Ketelaars SLC, Peters D, Lange CAH, van Werkhoven E, van Tinteren H, Mandjes IAM, Kemper I, Onderwater S, Chalabi M, Wilgenhof S, Haanen JBAG, Salgado R, de Visser KE, Sonke GS, Wessels LFA, Linn SC, Schumacher TN, Blank CU, Kok M.

Nat Med. 2019 Jul;25(7):1175. doi: 10.1038/s41591-019-0520-5.

PMID:
31209337
13.

A reply to Hurley et al. regarding Recipients Receiving Better HLA-Matched Hematopoietic Cell Transplantation Grafts, Uncovered by a Novel HLA Typing Method, Have Superior Survival: A Retrospective Study.

Mayor NP, Hayhurst JD, Turner TR, Szydlo RM, Shaw BE, Bultitude WP, Sayno JR, Tavarozzi F, Latham K, Anthias C, Robinson J, Braund H, Danby R, Perry J, Wilson MC, Bloor AJ, McQuaker IG, MacKinnon S, Marks DI, Pagliuca A, Potter MN, Potter VT, Russell NH, Thomson KJ, Madrigal JA, Marsh SGE.

Biol Blood Marrow Transplant. 2019 Aug;25(8):e270-e271. doi: 10.1016/j.bbmt.2019.06.005. Epub 2019 Jun 11. No abstract available.

PMID:
31195138
14.

Quizartinib versus salvage chemotherapy in relapsed or refractory FLT3-ITD acute myeloid leukaemia (QuANTUM-R): a multicentre, randomised, controlled, open-label, phase 3 trial.

Cortes JE, Khaled S, Martinelli G, Perl AE, Ganguly S, Russell N, Krämer A, Dombret H, Hogge D, Jonas BA, Leung AY, Mehta P, Montesinos P, Radsak M, Sica S, Arunachalam M, Holmes M, Kobayashi K, Namuyinga R, Ge N, Yver A, Zhang Y, Levis MJ.

Lancet Oncol. 2019 Jul;20(7):984-997. doi: 10.1016/S1470-2045(19)30150-0. Epub 2019 Jun 4. Erratum in: Lancet Oncol. 2019 Jul;20(7):e346.

PMID:
31175001
15.

Assessing Reality Testing in Mice Through Dopamine-Dependent Associatively Evoked Processing of Absent Gustatory Stimuli.

Fry BR, Russell N, Gifford R, Robles CF, Manning CE, Sawa A, Niwa M, Johnson AW.

Schizophr Bull. 2019 May 31. pii: sbz043. doi: 10.1093/schbul/sbz043. [Epub ahead of print]

PMID:
31150554
16.

Rounded intraplacental hematoma - A high risk placental lesion as illustrated by a prospective study of 26 consecutive cases.

Neville G, Russell N, O'Donoghue K, Fitzgerald B.

Placenta. 2019 Jun;81:18-24. doi: 10.1016/j.placenta.2019.02.011. Epub 2019 Feb 23.

PMID:
31138427
17.

MECHANISMS IN ENDOCRINOLOGY: Estradiol as a male hormone.

Russell N, Grossmann M.

Eur J Endocrinol. 2019 May 1. pii: EJE-18-1000.R2. doi: 10.1530/EJE-18-1000. [Epub ahead of print] Review.

PMID:
31096185
18.

HIV, syphilis, and viral hepatitis among Latin American indigenous peoples and Afro-descendants: a systematic review.

Russell NK, Nazar K, Del Pino S, Alonso Gonzalez M, Díaz Bermúdez XP, Ravasi G.

Rev Panam Salud Publica. 2019 Jan 4;43:e17. doi: 10.26633/RPSP.2019.17. eCollection 2019. Review.

19.

Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial.

Voorwerk L, Slagter M, Horlings HM, Sikorska K, van de Vijver KK, de Maaker M, Nederlof I, Kluin RJC, Warren S, Ong S, Wiersma TG, Russell NS, Lalezari F, Schouten PC, Bakker NAM, Ketelaars SLC, Peters D, Lange CAH, van Werkhoven E, van Tinteren H, Mandjes IAM, Kemper I, Onderwater S, Chalabi M, Wilgenhof S, Haanen JBAG, Salgado R, de Visser KE, Sonke GS, Wessels LFA, Linn SC, Schumacher TN, Blank CU, Kok M.

Nat Med. 2019 Jun;25(6):920-928. doi: 10.1038/s41591-019-0432-4. Epub 2019 May 13. Erratum in: Nat Med. 2019 Jun 17;:.

PMID:
31086347
20.

Allogeneic hematopoietic cell transplantation improves outcome of adults with t(6;9) acute myeloid leukemia - results from an international collaborative study.

Kayser S, Hills RK, Luskin MR, Brunner AM, Terré C, Westermann J, Menghrajani K, Shaw C, Baer MR, Elliott MA, Perl AE, Ráčil Z, Mayer J, Zak P, Szotkowski T, de Botton S, Grimwade D, Mayer K, Walter RB, Krämer A, Burnett AK, Ho AD, Platzbecker U, Thiede C, Ehninger G, Stone RM, Röllig C, Tallman MS, Estey EH, Müller-Tidow C, Russell NH, Schlenk RF, Levis MJ.

Haematologica. 2019 Apr 19. pii: haematol.2018.208678. doi: 10.3324/haematol.2018.208678. [Epub ahead of print]

21.

The prognostic impact of the cytomegalovirus serostatus in patients with chronic hematological malignancies after allogeneic hematopoietic stem cell transplantation: a report from the Infectious Diseases Working Party of EBMT.

Schmidt-Hieber M, Tridello G, Ljungman P, Mikulska M, Knelange N, Blaise D, Socié G, Volin L, Blijlevens N, Fegueux N, Yakoub-Agha I, Forcade E, Maertens J, Chevallier P, Passweg J, Cornelissen J, Russell N, Craddock C, Bourhis JH, Marchand T, Reményi P, Cahn JY, Michallet M, Montoto S, Kröger N, Glaß B, Styczynski J.

Ann Hematol. 2019 Jul;98(7):1755-1763. doi: 10.1007/s00277-019-03669-z. Epub 2019 Apr 16.

PMID:
30993417
22.

A Reliable and Reproducible Critical-Sized Segmental Femoral Defect Model in Rats Stabilized with a Custom External Fixator.

Kerzner B, Martin HL, Weiser M, Fontana G, Russell N, Murphy WL, Lund EA, Doro CJ.

J Vis Exp. 2019 Mar 24;(145). doi: 10.3791/59206.

PMID:
30958483
23.

Recipients Receiving Better HLA-Matched Hematopoietic Cell Transplantation Grafts, Uncovered by a Novel HLA Typing Method, Have Superior Survival: A Retrospective Study.

Mayor NP, Hayhurst JD, Turner TR, Szydlo RM, Shaw BE, Bultitude WP, Sayno JR, Tavarozzi F, Latham K, Anthias C, Robinson J, Braund H, Danby R, Perry J, Wilson MC, Bloor AJ, McQuaker IG, MacKinnon S, Marks DI, Pagliuca A, Potter MN, Potter VT, Russell NH, Thomson KJ, Madrigal JA, Marsh SGE.

Biol Blood Marrow Transplant. 2019 Mar;25(3):443-450. doi: 10.1016/j.bbmt.2018.12.768.

24.

Contrasting requirements during disease evolution identify EZH2 as a therapeutic target in AML.

Basheer F, Giotopoulos G, Meduri E, Yun H, Mazan M, Sasca D, Gallipoli P, Marando L, Gozdecka M, Asby R, Sheppard O, Dudek M, Bullinger L, Döhner H, Dillon R, Freeman S, Ottmann O, Burnett A, Russell N, Papaemmanuil E, Hills R, Campbell P, Vassiliou GS, Huntly BJP.

J Exp Med. 2019 Apr 1;216(4):966-981. doi: 10.1084/jem.20181276. Epub 2019 Mar 19.

25.

Charging undocumented migrant children for NHS healthcare: implications for child health.

Russell NJ, Murphy L, Nellums L, Broad J, Boutros S, Sigona N, Devakumar D.

Arch Dis Child. 2019 Aug;104(8):722-724. doi: 10.1136/archdischild-2018-316474. Epub 2019 Mar 14. No abstract available.

PMID:
30872274
26.

Surface plasmon resonance imaging of excitable cells.

Howe CL, Webb KF, Abayzeed SA, Anderson DJ, Denning C, Russell NA.

J Phys D Appl Phys. 2019 Mar 6;52(10):104001. doi: 10.1088/1361-6463/aaf849. Epub 2019 Jan 4.

27.

Simplex-based navigation tool for a posteriori selection of the preferred deformable image registration outcome from a set of trade-off solutions obtained with multiobjective optimization for the case of breast MRI.

Pirpinia K, Bosman PAN, Loo CE, Russell NS, van Herk MB, Alderliesten T.

J Med Imaging (Bellingham). 2018 Oct;5(4):045501. doi: 10.1117/1.JMI.5.4.045501. Epub 2018 Oct 30.

PMID:
30840735
28.

DNA damage corrects the aberrant cytoplasmic localisation of nucleophosmin in NPM1 mutated acute myeloid leukaemia.

Bailey GD, Qutob HMH, Akhtar A, Russell NH, Seedhouse CH.

Br J Haematol. 2019 Jul;186(2):343-347. doi: 10.1111/bjh.15823. Epub 2019 Mar 5. No abstract available.

29.

Correction: High expression of HMGA2 independently predicts poor clinical outcomes in acute myeloid leukemia.

Marquis M, Beaubois C, Lavallée VP, Abrahamowicz M, Danieli C, Lemieux S, Ahmad I, Wei A, Ting SB, Fleming S, Schwarer A, Grimwade D, Grey W, Hills RK, Vyas P, Russell N, Sauvageau G, Hébert J.

Blood Cancer J. 2019 Feb 28;9(3):28. doi: 10.1038/s41408-019-0190-z.

30.

Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNet.

Sanz MA, Fenaux P, Tallman MS, Estey EH, Löwenberg B, Naoe T, Lengfelder E, Döhner H, Burnett AK, Chen SJ, Mathews V, Iland H, Rego E, Kantarjian H, Adès L, Avvisati G, Montesinos P, Platzbecker U, Ravandi F, Russell NH, Lo-Coco F.

Blood. 2019 Apr 11;133(15):1630-1643. doi: 10.1182/blood-2019-01-894980. Epub 2019 Feb 25. Review.

31.

epiCaPture: A Urine DNA Methylation Test for Early Detection of Aggressive Prostate Cancer.

O'Reilly E, Tuzova AV, Walsh AL, Russell NM, O'Brien O, Kelly S, Dhomhnallain ON, DeBarra L, Dale CM, Brugman R, Clarke G, Schmidt O, O'Meachair S, Patil D, Pellegrini KL, Fleshner N, Garcia J, Zhao F, Finn S, Mills R, Hanna MY, Hurst R, McEvoy E, Gallagher WM, Manecksha RP, Cooper CS, Brewer DS, Bapat B, Sanda MG, Clark J, Perry AS.

JCO Precis Oncol. 2019;2019. doi: 10.1200/PO.18.00134. Epub 2019 Jan 14.

32.

Genetic biomarkers predict response to dual BCL-2 and MCL-1 targeting in acute myeloid leukaemia cells.

Grundy M, Balakrishnan S, Fox M, Seedhouse CH, Russell NH.

Oncotarget. 2018 Dec 28;9(102):37777-37789. doi: 10.18632/oncotarget.26540. eCollection 2018 Dec 28.

33.

The influence of adjuvant systemic regimens on contralateral breast cancer risk and receptor subtype.

Kramer I, Schaapveld M, Oldenburg HSA, Sonke GS, McCool D, van Leeuwen FE, Van de Vijver KK, Russell NS, Linn SC, Siesling S, Menke-van der Houven van Oordt CW, Schmidt MK.

J Natl Cancer Inst. 2019 Jan 30. doi: 10.1093/jnci/djz010. [Epub ahead of print]

PMID:
30698719
34.

Targeting FLT3 mutations in AML: review of current knowledge and evidence.

Daver N, Schlenk RF, Russell NH, Levis MJ.

Leukemia. 2019 Feb;33(2):299-312. doi: 10.1038/s41375-018-0357-9. Epub 2019 Jan 16. Review.

35.

Not So Fast: Autistic traits and Anxious Apprehension in Real-World Visual Search Scenarios.

Russell NCC, Luke SG, Lundwall RA, South M.

J Autism Dev Disord. 2019 May;49(5):1795-1806. doi: 10.1007/s10803-018-03874-1.

PMID:
30617769
36.

Functional MRI connectivity of children with autism and low verbal and cognitive performance.

Gabrielsen TP, Anderson JS, Stephenson KG, Beck J, King JB, Kellems R, Top DN Jr, Russell NCC, Anderberg E, Lundwall RA, Hansen B, South M.

Mol Autism. 2018 Dec 27;9:67. doi: 10.1186/s13229-018-0248-y. eCollection 2018.

37.

Genetic susceptibility to radiation-induced breast cancer after Hodgkin lymphoma.

Opstal-van Winden AWJ, de Haan HG, Hauptmann M, Schmidt MK, Broeks A, Russell NS, Janus CPM, Krol ADG, van der Baan FH, De Bruin ML, van Eggermond AM, Dennis J, Anton-Culver H, Haiman CA, Sawyer EJ, Cox A, Devilee P, Hooning MJ, Peto J, Couch FJ, Pharoah P, Orr N, Easton DF, Aleman BMP, Strong LC, Bhatia S, Cooke R, Robison LL, Swerdlow AJ, van Leeuwen FE.

Blood. 2019 Mar 7;133(10):1130-1139. doi: 10.1182/blood-2018-07-862607. Epub 2018 Dec 20.

PMID:
30573632
38.

Allogeneic stem cell transplantation as part of front line therapy for Mantle cell lymphoma.

Rule S, Cook G, Russell NH, Hunter A, Robinson S, Morley N, Sureda A, Patrick P, Clifton-Hadley L, Adedayo T, Kirkwood A, Peggs KS.

Br J Haematol. 2019 Mar;184(6):999-1005. doi: 10.1111/bjh.15723. Epub 2018 Dec 17.

PMID:
30560573
39.

Lenalidomide maintenance versus observation for patients with newly diagnosed multiple myeloma (Myeloma XI): a multicentre, open-label, randomised, phase 3 trial.

Jackson GH, Davies FE, Pawlyn C, Cairns DA, Striha A, Collett C, Hockaday A, Jones JR, Kishore B, Garg M, Williams CD, Karunanithi K, Lindsay J, Jenner MW, Cook G, Russell NH, Kaiser MF, Drayson MT, Owen RG, Gregory WM, Morgan GJ; UK NCRI Haemato-oncology Clinical Studies Group.

Lancet Oncol. 2019 Jan;20(1):57-73. doi: 10.1016/S1470-2045(18)30687-9. Epub 2018 Dec 14.

40.

Children and adolescents on the move: what does the Global Compact for Migration mean for their health?

Devakumar D, Russell N, Murphy L, Wickramage K, Sawyer SM, Abubakar I.

Lancet Child Adolesc Health. 2019 Feb;3(2):64-66. doi: 10.1016/S2352-4642(18)30376-6. Epub 2018 Dec 6. No abstract available.

PMID:
30528682
41.

Induction response criteria in acute myeloid leukaemia: implications of a flow cytometric measurable residual disease negative test in refractory adults.

Freeman SD, Hills RK, Russell NH; UK NCRI AML Trial Group, Cloos J, Kelder A, Ossenkoppele GJ, Schuurhuis GJ; HOVON AML Trial Group.

Br J Haematol. 2019 Jul;186(1):130-133. doi: 10.1111/bjh.15698. Epub 2018 Dec 5. No abstract available.

PMID:
30520018
42.

Management of bone and metabolic effects of androgen deprivation therapy.

Russell N, Grossmann M.

Urol Oncol. 2018 Nov 13. pii: S1078-1439(18)30389-2. doi: 10.1016/j.urolonc.2018.10.007. [Epub ahead of print] Review.

PMID:
30446463
43.

Quality of life after postmastectomy radiotherapy in patients with intermediate-risk breast cancer (SUPREMO): 2-year follow-up results of a randomised controlled trial.

Velikova G, Williams LJ, Willis S, Dixon JM, Loncaster J, Hatton M, Clarke J, Kunkler IH, Russell NS; MRC SUPREMO trial UK investigators.

Lancet Oncol. 2018 Nov;19(11):1516-1529. doi: 10.1016/S1470-2045(18)30515-1. Epub 2018 Oct 15. Erratum in: Lancet Oncol. 2018 Dec;19(12):e668.

44.

The use of random forests modelling to detect yeast-mannan sensitive bacterial changes in the broiler cecum.

Corrigan A, Russell N, Welge M, Auvil L, Bushell C, White BA, Murphy RA.

Sci Rep. 2018 Sep 5;8(1):13270. doi: 10.1038/s41598-018-31438-x.

45.

Financial costs of pursuing postgraduate residency training.

Hammond DA, Russell N, Davis NC, Caballero J, Garner SS, Sorensen TD, Watchmaker C, Bookstaver PB.

Am J Health Syst Pharm. 2018 Sep 1;75(17):1266-1267. doi: 10.2146/ajhp180047. No abstract available.

PMID:
30139733
46.

The Mastocytosis Society Survey on Mast Cell Disorders: Part 2-Patient Clinical Experiences and Beyond.

Russell N, Jennings S, Jennings B, Slee V, Sterling L, Castells M, Valent P, Akin C.

J Allergy Clin Immunol Pract. 2019 Apr;7(4):1157-1165.e6. doi: 10.1016/j.jaip.2018.07.032. Epub 2018 Aug 8.

47.

Attenuated arsenic trioxide plus ATRA therapy for newly diagnosed and relapsed APL: long-term follow-up of the AML17 trial.

Russell N, Burnett A, Hills R, Betteridge S, Dennis M, Jovanovic J, Dillon R, Grimwade D; NCRI AML Working Group.

Blood. 2018 Sep 27;132(13):1452-1454. doi: 10.1182/blood-2018-05-851824. Epub 2018 Aug 10. No abstract available.

48.

Ebola Medals returned to the UK Government in protest.

Russell N, Verrecchia R, Kahn C, Goldberg G, Menezes DB.

Lancet. 2018 Sep 1;392(10149):733. doi: 10.1016/S0140-6736(18)31735-5. Epub 2018 Jul 30. No abstract available.

PMID:
30072037
49.

Cardiovascular disease incidence after internal mammary chain irradiation and anthracycline-based chemotherapy for breast cancer.

Boekel NB, Jacobse JN, Schaapveld M, Hooning MJ, Gietema JA, Duane FK, Taylor CW, Darby SC, Hauptmann M, Seynaeve CM, Baaijens MHA, Sonke GS, Rutgers EJT, Russell NS, Aleman BMP, van Leeuwen FE.

Br J Cancer. 2018 Aug;119(4):408-418. doi: 10.1038/s41416-018-0159-x. Epub 2018 Aug 1.

50.

High expression of HMGA2 independently predicts poor clinical outcomes in acute myeloid leukemia.

Marquis M, Beaubois C, Lavallée VP, Abrahamowicz M, Danieli C, Lemieux S, Ahmad I, Wei A, Ting SB, Fleming S, Schwarer A, Grimwade D, Grey W, Hills RK, Vyas P, Russell N, Sauvageau G, Hébert J.

Blood Cancer J. 2018 Jul 19;8(8):68. doi: 10.1038/s41408-018-0103-6. Erratum in: Blood Cancer J. 2019 Feb 28;9(3):28.

Supplemental Content

Loading ...
Support Center